Status:
COMPLETED
Estrogen Treatment (Oral vs. Patches) in Turner Syndrome
Lead Sponsor:
Nemours Children's Clinic
Collaborating Sponsors:
Eli Lilly and Company
Conditions:
Turner Syndrome
Hypogonadism
Eligibility:
FEMALE
10-16 years
Phase:
PHASE3
Brief Summary
The study attempts to evaluate if the way of administering estrogen, the principal female hormone, via patches or orally, affects the way estrogen works in girls with Turner Syndrome. These are girls ...
Detailed Description
Girls with Turner Syndrome, between the ages of 10-16 years, were chosen as the study population. The study requires 3 overnight admissions to an in-patient Clinical Research Center(CRC). A baseline s...
Eligibility Criteria
Inclusion
- Girls with Turner syndrome 10-16 years old who are receiving growth hormone treatment.
- \-
Exclusion
- Systemic disease or concomitant treatment wtih Oxandrolone. Significant obesity or chronic steroid use.
- \-
Key Trial Info
Start Date :
January 1 2001
Trial Type :
INTERVENTIONAL
End Date :
June 1 2004
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00140998
Start Date
January 1 2001
End Date
June 1 2004
Last Update
November 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nemours Children's Clinic
Jacksonville, Florida, United States, 32207